Patents/Assignees

Gilead Sciences, Inc.

201 patents in portfolio

US12358903utility2025
FXR (NR1H4) Modulating Compounds
0 cites
US12357577utility2025
Pharmaceutical Formulations and Uses Thereof
0 cites
US12358887utility2025
IKAROS Zinc Finger Family Degraders and Uses Thereof
0 cites
US12338278utility2025
Antibodies That Target HIV Gp120 and Methods of Use
0 cites
US12338233utility2025
Pd-1/pd-l1 Inhibitors
0 cites
USD1079465design2025
Carton
0 cites
USD1075518design2025
Blister Pack
0 cites
US12297226utility2025
Compounds and Methods for Treatment of Viral Infections
0 cites
US12297282utility2025
Nucleic Acids Encoding, and Methods of Producing, Antibodies That Bind Human Chemokine (C—C Motif) Receptor 8 (CCR8)
0 cites
US12269812utility2025
PD-1/PD-L1 Inhibitors
0 cites
US12264173utility2025
Antiviral Compounds
0 cites
US12258346utility2025
Substituted 6-azabenzimidazole Compounds
0 cites
USD1064842design2025
Blister Pack
0 cites
US12240862utility2025
Inhibitors of Peptidylarginine Deiminases
0 cites
USD1063638design2025
Blister Pack
0 cites
US12227520utility2025
Bridged Tricyclic Carbamoylpyridone Compounds and Their Pharmaceutical Use
0 cites
US12208110utility2025
Phospholipid Compounds and Uses Thereof
0 cites
US12202782utility2025
Processes and Intermediates for Preparing MCL1 Inhibitors
0 cites
US12202842utility2025
MCL1 Inhibitors
0 cites
US12202849utility2025
Crystalline Forms of Tenofovir Alafenamide
0 cites

← PreviousPage 3 of 11Next →